Department of Dermatology, Kanazawa Medical University, Ishikawa, Japan.
Med Mycol. 2020 Apr 1;58(3):401-403. doi: 10.1093/mmy/myz056.
The viability of pathogenic fungi in the scale was investigated during topical administration of 1% luliconazole (LLCZ). Thirteen tinea pedis patients found to be positive on KOH examination were assessed by mycological examinations and quantitative real-time polymerase chain reaction (PCR) targeted internal transcribed spacer (ITS) in ribosomal RNA gene at the initial visit and after 2 and 4 weeks of treatment. Assays showed that the average copy number of ITS DNA had significantly decreased to 22.9% at 2 weeks and 4.8% at 4 weeks compared with the initial visit. LLCZ topical treatment could defeat almost pathogenic dermatophytes in the scales within 4 weeks.
在局部应用 1%卢立康唑(LLCZ)期间,研究了致病性真菌在鳞屑中的生存能力。对 13 名足部癣患者进行了检查,他们在 KOH 检查中呈阳性,在初次就诊时和治疗 2 周和 4 周后,通过真菌学检查和针对核糖体 RNA 基因内转录间隔区(ITS)的定量实时聚合酶链反应(PCR)进行了评估。检测结果显示,与初次就诊时相比,ITS DNA 的平均拷贝数在 2 周时显著下降至 22.9%,在 4 周时下降至 4.8%。LLCZ 局部治疗可在 4 周内消除鳞屑中几乎所有的致病性皮肤癣菌。